Manifest / 08
About Wolverine Source
An independent editorial dispatch on the BPC-157 TB-500 research record — what it is, what it is not, and how it is sourced.
What this site is
Wolverine Source is an independent editorial project that publishes summaries of the peer-reviewed research literature on the BPC-157 TB-500 blend and its two constituents. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.
The site is built as a dispatch console — a two-lane manifest — because that structure fits the subject. Wolverine is not one molecule but two peptides traveling together, and the honest story of the pairing is partly a channel story: where the material comes from, what regulatory status it carries, and what the published evidence does and does not establish. Rendering each finding and each regulatory fact as a scannable manifest line is how we keep that record legible and verifiable.
What 'Source' means here
The word "Source" in the domain is editorial framing, not a claim about services. It signals a channel-of-record register — a point from which the published research and the regulatory status are tracked and logged — not a storefront and not a supply channel. We do not offer treatment, consultation, prescription, or supply of any kind, and nothing on this site is for sale.
That distinction matters because the subject invites confusion. The blend is marketed and discussed widely online; this site exists to summarize the underlying literature and the regulatory landscape, plainly and with citations, so a reader can see what is established, what is theoretical, and what is simply absent.
How it is sourced
Every quantitative claim on the site maps to a numbered entry in the full reference list: the preclinical studies for each constituent, recent systematic and narrative reviews, the doping-control literature, and FDA primary sources for the compounding status. Where the evidence is precise — a structural result, a reported animal-model dose — we state it precisely. Where it is absent — no controlled combination trial, no validated human pharmacokinetics — we state that too, in the same ink. The negative space on the manifest is part of the record.